U.S. Food and Drug Administration (FDA) · United States

FDA Healthcare Social Media Marketing

Social media promotion that names a prescription drug or restricted device and makes a benefit claim must present the most serious risks in the same post with balanced prominence and a link to full risk information.

21 U.S.C. 352(a), (n); 21 CFR 202.1(e); FDA Character Space Draft Guidance (2014)

What is FDA Healthcare Social Media Marketing?

Social media promotion that names a prescription drug or restricted device and makes a benefit claim must present the most serious risks in the same post with balanced prominence and a link to full risk information. Rx drug and restricted device social posts, videos, stories and paid influencer content on any platform.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients · Prescription Drug, Medical Device · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

social_media, paid_social, video

When does this rule take effect?

2026-05-10

What does this rule require?

Social media promotion that names a prescription drug or restricted device and makes a benefit claim must present the most serious risks in the same post with balanced prominence and a link to full risk information.

How can marketing teams comply?

Rx drug and restricted device social posts, videos, stories and paid influencer content on any platform.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (FDA)
Jurisdiction
United States
Official citation
21 U.S.C. 352(a), (n); 21 CFR 202.1(e); FDA Character Space Draft Guidance (2014)
Published
2026-11-16
Effective date
2026-05-10
Channel
social_media, paid_social, video
Products
Prescription Drug, Medical Device
Audiences
general_audience, general_adults_18plus, customers, patients

Frequently asked questions

What is FDA Healthcare Social Media Marketing?

Social media promotion that names a prescription drug or restricted device and makes a benefit claim must present the most serious risks in the same post with balanced prominence and a link to full risk information.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, patients · Prescription Drug, Medical Device · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

social_media, paid_social, video

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan